Treatment
Daridorexant clinical trials
We’re tracking 6 recruiting studies that include Daridorexant, each written for real people, not researchers, below.
Recruiting studies
- NCT05924425RecruitingPhase 4
Daridorexant for insomnia in early memory decline
This trial tests whether daridorexant can improve sleep in people who have mild cognitive impairment or early Alzheimer’s disease and struggle with insomnia. It may help by improving how long and how well you sleep, with monitoring of sleep patterns and memory-related measures.
MontpellierAges 60–85 - NCT07136415RecruitingPhase 4
Comparing digital therapy, trazodone, and daridorexant for menopause insomnia
This trial tests three different treatments for insomnia that started or got worse during the menopausal transition. One is a digital therapy app, and the others are two different medications. The goal is to see which works best for women aged 40–62 who are in the early stages of menopause.
Boston, MassachusettsAges 40–62 - NCT07213349RecruitingPhase 2
Daridorexant for Alzheimer's prevention
This study tests whether daridorexant, a medication that helps improve sleep, can prevent Alzheimer's disease. If you have mild memory concerns but not dementia, this trial may help find out if better sleep can protect your brain.
Montreal, QuebecAges 50–90 - NCT07217912RecruitingPhase 2
Study of daridorexant to prevent confusion after heart surgery
This trial tests whether a sleep medication called daridorexant can help prevent delirium (sudden confusion) in older adults after heart surgery. You must be 60 or older and having a specific type of heart operation.
Rochester, New YorkAges 60 years+ - NCT07267559RecruitingPhase 4
Daridorexant and emotion brain testing study
This study tests a medication called daridorexant, which affects the brain's sleep-wake system, to see how it influences emotions and thinking. You will take one dose and complete computer tasks that measure how you process emotional information.
OxfordAges 18–40 - NCT06498128Recruiting
Pregnancy safety registry for insomnia drug QUVIVIQ
This registry follows pregnant women with insomnia who used or did not use the sleep medication QUVIVIQ. It aims to track pregnancy and baby outcomes to understand safety.
Durham, North CarolinaAges 15–50
What Daridorexant is being studied for
Conditions with recruiting Daridorexant studies.
Common questions
- Are there clinical trials studying Daridorexant?
- Yes. Clin2 currently lists 6 recruiting studies that include Daridorexant, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Daridorexant trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Daridorexant an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Daridorexant or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.